111 related articles for article (PubMed ID: 10677637)
21. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
22. A radioimmunoassay for cytosine arabinoside.
Piall EM; Aherne GW; Marks VM
Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting.
Nishikawa M; Kamijo A; Fujita T; Takakura Y; Sezaki H; Hashida M
Pharm Res; 1993 Sep; 10(9):1253-61. PubMed ID: 7694271
[TBL] [Abstract][Full Text] [Related]
24. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats].
Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T
Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764
[TBL] [Abstract][Full Text] [Related]
25. Intraocular penetration of cytosine arabinoside following subconjunctival administration in primates.
Graham ML; Smiddy WE; Cheo DL; Schachat AP
J Ocul Pharmacol; 1989; 5(3):255-9. PubMed ID: 2625619
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
Ho DH; Frei E
Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
[No Abstract] [Full Text] [Related]
27. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
Blasberg RG; Patlak C; Fenstermacher JD
J Pharmacol Exp Ther; 1975 Oct; 195(1):73-83. PubMed ID: 810575
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound-assisted convection-enhanced delivery to the brain in vivo with a novel transducer cannula assembly: laboratory investigation.
Lewis GK; Schulz ZR; Pannullo SC; Southard TL; Olbricht WL
J Neurosurg; 2012 Dec; 117(6):1128-40. PubMed ID: 22998056
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children.
Finklestein JZ; Scher J; Karon M
Cancer Chemother Rep; 1970 Feb; 54(1):35-9. PubMed ID: 5538163
[No Abstract] [Full Text] [Related]
30. Fabrication and characterization of microfluidic probes for convection enhanced drug delivery.
Neeves KB; Lo CT; Foley CP; Saltzman WM; Olbricht WL
J Control Release; 2006 Apr; 111(3):252-62. PubMed ID: 16476500
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
33. Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration.
Midgley I; Hood AJ; Proctor P; Chasseaud LF; Irons SR; Cheng KN; Brindley CJ; Bonn R
Xenobiotica; 1994 Jan; 24(1):79-92. PubMed ID: 8165824
[TBL] [Abstract][Full Text] [Related]
34. Intraocular penetration of cytosine arabinoside following intravenous administration in primates.
Smiddy WE; Graham ML; Cheo DL; Schachat AP
J Ocul Pharmacol; 1988; 4(2):133-6. PubMed ID: 3171337
[TBL] [Abstract][Full Text] [Related]
35. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
[TBL] [Abstract][Full Text] [Related]
36. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
38. Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer.
Croteau D; Walbridge S; Morrison PF; Butman JA; Vortmeyer AO; Johnson D; Oldfield EH; Lonser RR
J Neurosurg; 2005 Jan; 102(1):90-7. PubMed ID: 15658101
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside.
Weinstein HJ; Griffin TW; Feeney J; Cohen HJ; Propper RD; Sallan SE
Blood; 1982 Jun; 59(6):1351-3. PubMed ID: 7082832
[TBL] [Abstract][Full Text] [Related]
40. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
